Treatment should aim to control clinical signs of congestive heart failure (CHF) and aim to prevent arterial thromboembolism (ATE). In addition to this, consideration should be given to '''positive inotropic therapy'''. Treatment with positive inotropes, such as Pimobendan is indicated for severe systolic dysfunction and heart failure. | Treatment should aim to control clinical signs of congestive heart failure (CHF) and aim to prevent arterial thromboembolism (ATE). In addition to this, consideration should be given to '''positive inotropic therapy'''. Treatment with positive inotropes, such as Pimobendan is indicated for severe systolic dysfunction and heart failure. |